Wockhardt Ltd.

175.70 +7.55 ▲4.5%

06 June 2023, 04:01:00 PM
Volume: 87,480

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.wockhardt.com
Market Cap 2,531.74 Cr.
Enterprise Value(EV) 4,294.74 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -38.79 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 33.76 Trailing Twelve Months Ending 2023-03
Book Value / Share 232.77 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.75 Calculated using Price: 175.70
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 14.41 Cr. 144,094,573 Shares
FaceValue 5
About Wockhardt Ltd.
The company is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It has many research centres and several manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. It is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Wockhardt.

Wockhardt Ltd. Delivery

Delivered Qty
Traded Qty

Wockhardt Ltd. Performance

1 Day
+4.49%
1 Week
+3.38%
1 Month
+3.32%
3 Month
-8.87%
6 Month
-23.11%
1 Year
-33.16%
2 Year
-70.85%
5 Year
-70.63%
10 Year
-84.06%

Wockhardt Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 30.04 12.49 7.07 -6.42 -21.81 -11.43 -5.22 -9.92 -7.77
Return on Capital Employed (%) 18.98 11.25 6.87 -0.31 -5.47 -2.87 -1.11 -5.50 -1.96
Return on Assets (%) 13.36 5.84 3.25 -2.69 -7.93 -4.01 -1.80 -3.93 -3.71

Wockhardt Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 3,581 3,715 3,775 3,337 2,852 2,675 2,672 3,376 3,849 3,354
Non Curr. Liab. 1,161 1,872 1,893 3,151 2,089 1,703 1,195 496 261 -22
Curr. Liab. 1,743 1,773 1,842 1,979 2,692 2,864 3,497 3,121 3,207 3,435
Minority Int. 136 144 465 382 346 330 386 383 353 308
Equity & Liab. 6,622 7,505 7,976 8,849 7,978 7,571 7,749 7,376 7,670 7,075
Non Curr. Assets 3,266 3,983 4,024 4,314 4,599 4,756 5,320 4,951 5,081 4,867
Curr. Assets 3,356 3,522 3,952 4,535 3,380 2,815 2,401 2,425 2,589 2,208
Misc. Exp. not W/O
Total Assets 6,622 7,505 7,976 8,849 7,978 7,571 7,749 7,376 7,670 7,075

Wockhardt Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 4,830 4,482 4,453 4,015 3,937 3,566 2,844 2,708 3,230 2,651
Other Income 84 67 66 114 177 21 60 132 20 148
Total Income 4,915 4,548 4,519 4,129 4,114 3,587 2,904 2,840 3,250 2,799
Total Expenditure -3,851 -3,772 -3,959 -4,002 -3,992 -3,604 -2,746 -2,771 -2,932 -2,576
PBIDT 1,064 776 560 127 122 -17 158 69 318 223
Interest -83 -55 -129 -225 -255 -265 -276 -249 -299 -302
Depreciation -140 -145 -142 -149 -150 -164 -224 -246 -247 -251
Taxation -48 -163 -38 21 -26 135 204 271 132 3
Exceptional Items 50 -358 -142 -183 -294
PAT 843 413 252 -226 -667 -312 -138 -297 -279 -621
Minority Interest -2 -8 -2 30 59 22 -26 -2 35 61
Share Associate 0 1
Other Related Items -139
Consolidated Net Profit 702 405 251 -196 -608 -195 -69 686 -244 -560
Adjusted EPS 59 34 21 -16 -51 -16 -6 57 -17 -39

Wockhardt Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,532 1,476 355 72 -269 68 183 649 -287 413
Cash Fr. Inv. 1,085 -852 -207 -818 -687 630 95 -156 1,470 -201
Cash Fr. Finan. -2,246 -601 -76 254 1,254 -769 -776 -680 -1,171 -71
Net Change 372 23 73 -492 298 -71 -499 -186 12 141
Cash & Cash Eqvt 1,050 1,102 1,159 665 964 897 397 219 232 370

Wockhardt Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 72.12 69.68 68.04 67.13 67.13 65.75 63.83 60.36 59.31
Public 27.88 30.32 31.96 32.87 32.87 34.25 36.17 39.64 40.69
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 18.71 34.44 41.99 47.32 43.60 47.84 52.77 56.08 65.46

Wockhardt Ltd. Announcements

Fri, 26 May 2023
Outcome Of The Board Meeting
Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations); audited Financial Results of the Company as on March 31 2023 are enclosed.
Fri, 26 May 2023
Board Meeting Outcome for Outcome Of The Board Meeting
Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations); outcome of the Board meeting held today i.e. 26th May 2023 is enclosed.
Fri, 26 May 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of SEBI Listing Regulations please find enclosed Press Release on the Audited Financial Results (Standalone and Consolidated) for the quarter and the Financial Year ended March 31 2023.

Wockhardt Ltd. Technical Scans

Tue, 06 Jun 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below

Wockhardt Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,184.60 1,013.55 +0.4%
Divi's Laboratories Ltd. 93,886.95 3,536.65 +2.2%
Cipla Ltd. 78,522.76 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. 77,195.89 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. 71,115.89 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. 60,794.95 1,796.30 +1.2%
Mankind Pharma Ltd. 59,699.70 1,490.30 +4.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.70 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 51.49 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 28.02 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.13 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.83 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.83 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 44.71 1,490.30 +4.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.34 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.35 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 3.35 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.32 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.49 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.81 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 5.75 1,490.30 +4.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 0.04 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,490.30 +4.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,490.30 +4.6%

Wockhardt Ltd. FAQ's

What is Wockhardt share price?

Can I buy Wockhardt shares now?

What is the Market Cap of Wockhardt?

What are the key metrics to analyse Wockhardt?

What is the 52 Week High and Low of Wockhardt?

What is the trend of Wockhardt share price?